DISSO INDIA 2025 showcases global leadership in dissolution science & regulatory innovation. 

The 13th Annual International Symposium on Dissolution Science and Applications – Disso India 2025, organized by the Society for Pharmaceutical Dissolution Science (SPDS) in collaboration with SVKM’s Dr. Bhanuben Nanavati College of Pharmacy ( Autonomous) concluded in Mumbai with exceptional participation from leading scientists, regulators, industry experts, and international collaborators. The two-day event, themed “Advances in Dissolution Technology and Regulatory Implications for Quality,” reinforced India’s growing leadership in global pharmaceutical quality frameworks.

The theme for 2025 reflected the evolving analytical and regulatory landscape. Discussions emphasized the growing role of dissolution in formulation development, QbD frameworks, global harmonization, biowaiver pathways, and the evaluation of complex dosage forms. The scientific program captured multiple advanced domains. Speakers from India, the US, France, Europe, and ASEAN regions contributed to a highly technical and forward-looking discourse.

Disso India 2025 featured strong participation from High-Profile Regulatory Engagement. The inaugural function was graced by the Chair of the conference, Dr. Santosh Indraksha, Deputy Drugs Controller (India), CDSCO, Mumbai, Chief Guest, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, Guest of Honour, Dr. D. R. Gahane, State Drug Controller, Maharashtra and Dr. Bharat Shah, National President, IDMA. Their presence underscored the tightening nexus between scientific advancement and regulatory expectations related to dissolution testing and product performance.

Disso India 2025 featured a curated selection of global experts covering the full spectrum of dissolution science—from complex generics to inhalation, ophthalmic products, PBPK modelling, quality compliance, and in-vitro performance tools.

Key Scientific Speakers:

• Dr. Vinod Shah – Ex-USFDA, USA
  Regulatory Aspects of Biowaivers with Case Studies
• Dr. Pankaj Mandpe – Senior VP, Micro Labs
  Changing Paradigms in Dissolution Testing
• Dr. Narsimha Murthy – Chief Scientific Officer, Topical Products Testing LLC, USA
  IVRT & IVPT for Topical Products
• Dr. Samir Haddouchi – Managing Director, SOTAX Pharma Services, France
  Dissolution Testing of Non-Oral Complex Dosage Forms
• Prof. Mala Menon – Bombay College of Pharmacy
  Fate of Inhaled Drugs—Deposition, Dissolution & Permeation
• Pearl Pereira-Nambiar – Founder, RegXpert Pro
  Dissolution Method Development for Ophthalmic Formulations
• Dr. Sudeep Ojha – Zydus Lifesciences
  Coning During Dissolution Testing
• Dr. Deepak Hegde – Cipla Shanghai
  Industry Perspective & Regulatory Considerations
• Dr. Mark Liddell – USP, USA
  Compliance vs. Confidence in Dissolution Testing
• Sivacharan Kollipara – Dr. Reddy’s Laboratories
  PBPK Modelling & Novel In Vitro Tools
• Dr. Heni Rachmawati – Institut Teknologi Bandung, Indonesia
  Dissolution Media & In Vivo Relevance
• Mr. Satish Chitriv
  Volumetric Flask Quality in Dissolution Testing

Panel Discussions:

• “Dissolution Assessment of Complex Formulations – An Emerging Challenge”
  Moderator: Dr. Padma Devrajan, Advisor, SIES School of Pharmacy, Ex- Professor, Institute of Chemical technology
  Panelists: Maharukh Rustomjee, Dr. Parizad Elchidana, Prof. Mala Menon, Dr. Pankaj Mandpe, Pearl Perriera
• “Why Compliance with Dissolution Requirements Is Still a Challenge?”
  Moderator: Vijay Kshirsagar
  Panelists: Dr. Deepak Hegde, Dr. Mark Liddell, Dr. Vinod Shah, Dr. Adil Billimoria, Dr. Samir Haddouchi, Dr. Suhas yewale 

The conference was steered by the dynamic leadership of  Dr. Santosh Indraksha, Director, CDSCO , Chair of the Conference and Prof. Padma V. Devarajan (President, SPDS),  Mentored and supported by Dr. L. Ramaswamy (Secretary-General, SPDS). Dr. Munira Momin (Scientific Chair, SPDS), and Mr. Sunil Dubey (Organising Secretary & MD, SOTAX India)—each playing a defining role in shaping the scientific vision, execution, and international collaboration of this year’s edition. The event was platinum-sponsored by SOTAX  and ACG Worldwide and all other sponsors, Cytiva, USP, Electolab, Borosil, Micro tracer, Lab india, Biorelevant, Image provision, Media partner- Bluetech media , reflecting the their long-standing commitment to advancing dissolution instrumentation, compliance, and global best practices. They contributed significantly to the success of the conference.

With an impressive lineup of global experts, forward-looking regulatory deliberations, and strong industry–academia partnership, Disso India 2025 reaffirmed SPDS’s position as the world’s only professional body dedicated exclusively to dissolution science. The conference not only advanced high-value scientific discourse but also set the direction for future quality frameworks, technology adoption, and global harmonization in dissolution testing. As SPDS continues to expand through international collaborations and capacity-building initiatives, Disso India remains the flagship platform where science, regulation, and innovation converge to elevate pharmaceutical quality and patient safety worldwide.